{"id":228721,"date":"2026-09-03T10:54:11","date_gmt":"2026-09-03T05:24:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=228721"},"modified":"2026-09-03T10:54:12","modified_gmt":"2026-09-03T05:24:12","slug":"jyothy-labs-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jyothy-labs-share-price-buy-hold-or-sell\/","title":{"rendered":"Jyothy Labs: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"
<\/div>\n

Jyothy Labs share price Rs 202.09 (NSE), near its 52-week low. 52-week range Rs 188.10 to Rs 347. Q1 FY27 revenue up 3% YoY, profit fell about 51% on margin squeeze.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Jyothy Labs share price is trading around Rs 202, close to its 52-week low of Rs 188.10 and well off its 52-week high of Rs 347. Q1 FY27 revenue grew a modest 3 percent year on year to Rs 773 crore, but net profit fell sharply to Rs 47.64 crore from Rs 96.79 crore a year earlier, driven by severe gross margin compression as crude-linked input costs surged an estimated 30 to 35 percent during the quarter. The stock trades at 26.1 times earnings, a discount to the FMCG sector average near 38 times. Management expects margin recovery to be progressive from October if commodity prices stabilise, so investors who believe this recovery timeline may see the pullback as an opportunity, while others may prefer to wait for confirmation.<\/p>\n<\/div>\n

Jyothy Labs<\/a> share price is trading close to its 52-week low of Rs 188.10, with Jyothy Labs share price near Rs 202 on the NSE, well off its 52-week high of Rs 347. With volume growth overshadowed by unprecedented margin compression in Q1 FY27, investors are asking whether this home and personal care company is a stock to buy near its lows, a hold, or a sell given the severity of the cost pressure.<\/p>\n

This Jyothy Labs stock analysis walks through the Q1 FY27 numbers, the specific input cost drivers behind the margin squeeze, valuation against the FMCG sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n